/197A.T

197A.T Stock - TAUNS Laboratories, Inc.

Q: What is the analyst price target for 197A.T?

Analyst price target information is not currently available for 197A.T.

Q: What is 197A.T's market cap?

Market capitalization information is not currently available for 197A.T.

Healthcare|Medical - Specialties|JPX

$524.00-0.57%

$3.00 (-0.57%) • Dec 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $576.40

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for 197A.T

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2022

FY2023

FY2024

FY2025

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.42

52W High$733.00

52W Low$418.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022
Revenue	$18.63B	$18.43B	$15.67B	$17.46B
Gross Profit	$12.33B	$12.50B	$8.79B	$14.29B
Gross Margin	66.2%	67.8%	56.1%	81.8%
Operating Income	$8.27B	$8.03B	$4.97B	$11.19B
Net Income	$6.32B	$5.77B	$3.03B	$4.48B
Net Margin	33.9%	31.3%	19.4%	25.7%
EPS	$62.07	$57.74	$30.35	$44.81

Company Overview

TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. It also provides import and export of industrial measuring instruments, medical, physical, chemical and measuring instruments. The company was founded in April 1987 and is headquartered in Izunokuni, Japan.

Visit Website

Earnings History & Surprises

197A.T

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$3.33

Q4 2025

EPS Surprise History

Q2 24

No data

Q4 24

No data

Q1 25

No data

Q2 25

No data

Q3 25

No data

Q4 25

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Nov 14, 2025	—	$3.33	—	—
Q3 2025	Aug 13, 2025	—	$-3.05	—	—
Q2 2025	May 14, 2025	—	$17.94	—	—
Q1 2025	Feb 13, 2025	—	$18.55	—	—
Q4 2024	Nov 13, 2024	—	$25.20	—	—
Q3 2024	Aug 13, 2024	—	—	—	—
Q2 2024	Jun 29, 2024	—	$-1.32	—	—

Frequently Asked Questions about 197A.T

What is 197A.T's current stock price?

TAUNS Laboratories, Inc. (197A.T) is currently trading at $524.00 per share. The stock has moved -0.57% today.

What is the analyst price target for 197A.T?

No analyst price targets are currently available for this stock.

What sector is TAUNS Laboratories, Inc. in?

TAUNS Laboratories, Inc. operates in the Healthcare sector, specifically within the Medical - Specialties industry. The company is traded on the JPX exchange.

What is 197A.T's market cap?

TAUNS Laboratories, Inc. has a market capitalization of $54.08 billion, making it a large-cap company.

Does 197A.T pay dividends?

No, TAUNS Laboratories, Inc. does not currently pay a dividend to shareholders.